Blandino G - Search Results

1

The new world of RNA diagnostics and therapeutics.

Blandino G, Dinami R, Marcia M, Anastasiadou E, Ryan BM, Palcau AC, Fattore L, Regazzo G, Sestito R, Loria R, Díaz Méndez AB, Cappelletto MC, Pulito C, Monteonofrio L, Calin GA, Sozzi G, Cheong JK, Aharonov R, Ciliberto G. Blandino G, et al. J Exp Clin Cancer Res. 2023 Jul 29;42(1):189. doi: 10.1186/s13046-023-02752-8. J Exp Clin Cancer Res. 2023. PMID: 37507791 Free PMC article.

2

Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs.

Cioce M, Gherardi S, Viglietto G, Strano S, Blandino G, Muti P, Ciliberto G. Cioce M, et al. Among authors: blandino g. Cell Cycle. 2010 Jul 15;9(14):2878-87. Epub 2010 Jul 13. Cell Cycle. 2010. PMID: 20581442

3

Butein impairs the protumorigenic activity of malignant pleural mesothelioma cells.

Cioce M, Canino C, Pulito C, Muti P, Strano S, Blandino G. Cioce M, et al. Among authors: blandino g. Cell Cycle. 2012 Jan 1;11(1):132-40. doi: 10.4161/cc.11.1.18474. Epub 2012 Jan 1. Cell Cycle. 2012. PMID: 22185775

4

Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC.

Blandino G, Valerio M, Cioce M, Mori F, Casadei L, Pulito C, Sacconi A, Biagioni F, Cortese G, Galanti S, Manetti C, Citro G, Muti P, Strano S. Blandino G, et al. Nat Commun. 2012 May 29;3:865. doi: 10.1038/ncomms1859. Nat Commun. 2012. PMID: 22643892 Free article.

5

miR-155 drives telomere fragility in human breast cancer by targeting TRF1.

Dinami R, Ercolani C, Petti E, Piazza S, Ciani Y, Sestito R, Sacconi A, Biagioni F, le Sage C, Agami R, Benetti R, Mottolese M, Schneider C, Blandino G, Schoeftner S. Dinami R, et al. Among authors: blandino g. Cancer Res. 2014 Aug 1;74(15):4145-56. doi: 10.1158/0008-5472.CAN-13-2038. Epub 2014 May 29. Cancer Res. 2014. PMID: 24876105

6

Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention.

Pulito C, Sanli T, Rana P, Muti P, Blandino G, Strano S. Pulito C, et al. Among authors: blandino g. Metabolites. 2013 Nov 7;3(4):1051-75. doi: 10.3390/metabo3041051. Metabolites. 2013. PMID: 24958265 Free PMC article.

7

Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells.

Cioce M, Valerio M, Casadei L, Pulito C, Sacconi A, Mori F, Biagioni F, Manetti C, Muti P, Strano S, Blandino G. Cioce M, et al. Among authors: blandino g. Oncotarget. 2014 Jun 30;5(12):4129-43. doi: 10.18632/oncotarget.1864. Oncotarget. 2014. PMID: 24980829 Free PMC article.

8

microRNAs and cancer metabolism reprogramming: the paradigm of metformin.

Pulito C, Donzelli S, Muti P, Puzzo L, Strano S, Blandino G. Pulito C, et al. Among authors: blandino g. Ann Transl Med. 2014 Jun;2(6):58. doi: 10.3978/j.issn.2305-5839.2014.06.03. Ann Transl Med. 2014. PMID: 25333033 Free PMC article. Review.

9

Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.

Pulito C, Terrenato I, Di Benedetto A, Korita E, Goeman F, Sacconi A, Biagioni F, Blandino G, Strano S, Muti P, Mottolese M, Falvo E. Pulito C, et al. Among authors: blandino g. PLoS One. 2015 Apr 7;10(4):e0124894. doi: 10.1371/journal.pone.0124894. eCollection 2015. PLoS One. 2015. PMID: 25849303 Free PMC article.

10

MicroRNAs: short non-coding players in cancer chemoresistance.

Donzelli S, Mori F, Biagioni F, Bellissimo T, Pulito C, Muti P, Strano S, Blandino G. Donzelli S, et al. Among authors: blandino g. Mol Cell Ther. 2014 Jun 1;2:16. doi: 10.1186/2052-8426-2-16. eCollection 2014. Mol Cell Ther. 2014. PMID: 26056584 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters